Medicare Enrolled
Ricardo Kosturakis, M. D.
Interventional Cardiology · El Paso, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Kosturakis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Kosturakis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Kosturakis
Ricardo Kosturakis is an interventional cardiology specialist in El Paso, TX, with 13 years of NPI registration. Based on federal Medicare data, Kosturakis performed 2,246 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Kosturakis received a total of $12,292 from 47 pharmaceutical and/or device companies across 313 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Kosturakis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ 2,246 Medicare services
$12,292 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,246
Medicare services
Bottom 47% in TX for interventional cardiology
Not available
Unique patients (not deduplicated)
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,155 | $0 | $0 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
152 | $40 | $231 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
147 | $91 | $309 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
97 | $97 | $642 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
92 | $10 | $48 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
78 | $60 | $211 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
51 | $21 | $147 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
47 | $51 | $216 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
42 | $0 | $0 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
40 | $97 | $420 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
33 | $90 | $304 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 33 | $1,019 | $3,900 |
| New patient office visit, complex (60-74 min) | 30 | $144 | $595 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $67 | $212 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $97 | $403 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $133 | $593 |
| Injection, fentanyl citrate, 0.1 mg | 24 | $1 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $116 | $477 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
19 | $1,050 | $3,942 |
| Cardiac catheterization | 17 | $729 | $3,018 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
16 | $370 | $1,789 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
16 | $70 | $265 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
14 | $1,799 | $9,180 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
14 | $135 | $691 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
14 | $19 | $79 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
14 | $620 | $2,031 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.8% high complexity
65.4% medium
28.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,292
Total received (2018-2024)
Avg $1,756/year across 7 years
Top 38% in TX for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
313
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$957
2023
$954
2022
$575
2021
$2,114
2020
$3,516
2019
$3,051
2018
$1,125
Payments by company (2024)
Boston Scientific Corporation
$229
Inari Medical, Inc.
$188
Medtronic, Inc.
$142
Philips North America LLC
$96
Penumbra, Inc.
$79
Janssen Pharmaceuticals, Inc
$58
PFIZER INC.
$54
Novo Nordisk Inc
$37
Novartis Pharmaceuticals Corporation
$25
Kiniksa Pharmaceuticals International, plc
$18
Tactile Systems Technology Inc
$16
ShockWave Medical, Inc
$16
Top 3 companies account for 58.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,414
Abbott Laboratories
$1,239
Edwards Lifesciences Corporation
$1,237
Medtronic Vascular, Inc.
$1,233
Cook Medical LLC
$1,039
Medtronic, Inc.
$923
AstraZeneca Pharmaceuticals LP
$586
ABIOMED
$527
Novartis Pharmaceuticals Corporation
$481
Inari Medical, Inc.
$407
Shockwave Medical, Inc
$334
Cardiovascular Systems Inc.
$287
ASAHI INTECC USA, INC.
$258
PFIZER INC.
$242
Philips Electronics North America Corporation
$232
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$202
Amgen Inc.
$170
ACIST MEDICAL SYSTEMS, INC.
$153
E.R. Squibb & Sons, L.L.C.
$133
Chiesi USA, Inc.
$128
Janssen Pharmaceuticals, Inc
$116
Philips North America LLC
$96
Acist Medical Systems, Inc.
$94
CHIESI USA, INC.
$80
Penumbra, Inc.
$79
ShockWave Medical, Inc
$71
Gilead Sciences, Inc.
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
BOSTON SCIENTIFIC CORPORATION
$47
Novo Nordisk Inc
$37
Lundbeck LLC
$31
Daiichi Sankyo Inc.
$24
Impulse Dynamics (USA) Inc.
$24
AngioDynamics, Inc.
$20
HeartFlow, Inc.
$20
PORTOLA PHARMACEUTICALS, INC.
$19
Otsuka America Pharmaceutical, Inc.
$19
Kiniksa Pharmaceuticals International, plc
$18
United Therapeutics Corporation
$18
Tactile Systems Technology Inc
$16
iRhythm Technologies, Inc.
$16
Merck Sharp & Dohme LLC
$15
Kiniksa Pharmaceuticals, Ltd.
$15
Actelion Pharmaceuticals US, Inc.
$15
Relypsa, Inc.
$13
Bard Peripheral Vascular, Inc.
$12
CVRx, Inc.
$11
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
(BR5) Peripheral IVUS · ANDEXXA · ASAHI PTCA Guide Wire · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · Amplatz · Arcalyst · BRILINTA · Barostim Neo System · CAMZYOS · CLINICAL TRIAL PRODUCT · COOK MEDICAL ZILVER PTX · CT THROMBECTOMY SYSTEM KIT · CVI Consumables · CVI Systems · CardioMEMS HF System · Cook Medical Catheters · Cook Medical Embolization · Cook Medical Peripheral Intervention · Cook Medical Stents · Cook Medical Zilver PTX · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · CrossBoss · ELIQUIS · EMBLEM MRI S-ICD · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EkoSonic · FARXIGA · FFRct · FLOWTRIEVER CATHETER · Flexitouch Plus · GALLANT · GENERAL STENTS · GENERAL - STENTS · GENERAL - THERAPIES · GENERAL BRADY · HARMONY · HAWKONE · HD-IVUS · HawkOne · HeartMate 3 Left Ventricular Dev · HeartWare HVAD · Hornet 10 · IGT D Coronary · INGEVITY MRI · INGEVITY+ · INJECTAFER · Impella · JARDIANCE · JOT DX · JUDO 3 · KENGREAL · KENGREAL 50MG/10ML L · LATITUDE Communicator Power Supply · LEQVIO · LINQ II · LOTUS EDGE · LUX-Dx Insertable Cardiac Monitor · LifeVest · MAMBA · NORTHERA · ONYX FRONTIER · OPSUMIT · OPTIMIZER · ORENITRAM · Optis Coronary Imaging System · Ozempic · POLARIS · Penumbra System · Perclose ProGlide suture mediated closure system · Performer · PressureWire FFR · RESOLUTE ONYX · RESONATE · ROTAPRO · Repatha · Resolute · S · SAMSCA · SYMPLICITY G3 · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Stingray · Ultraverse 014 · VENASEAL · VERQUVO · VIGILANT · VYNDAQEL · Vascular Lithotripsy · Veltassa · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · Xience Sierra Coronary Stent System · Xience V coronary stent system · ZIO Patch · Zilver PTX · myLUX Patient Kit with mobile device
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Interventional cardiologists in nearby ZIP areas
12
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Kosturakis is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Kosturakis experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Kosturakis performed 1,155 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Kosturakis receive payments from pharmaceutical companies?
Yes. Kosturakis received a total of $12,292 from 47 companies across 313 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Kosturakis's costs compare to other interventional cardiologists in El Paso?
Kosturakis's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Kosturakis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in El Paso
Browse interventional cardiologists in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in TX
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in TX
Which TX interventional cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology